Related Experiment Video
Updated: Mar 19, 2026

Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
Improving asthma control assessment and outcomes in children with asthma using an artificial intelligence digital
Anne B Chang1,2,3, Stephanie T Yerkovich1,2, Steven M McPhail4
1Cough, Asthma and Airways Group, Australian Centre for Health Services Innovation and School of Medicine, Queensland University of Technology, Brisbane, QLD, Australia.
Insights
Objectively assessing wheeze in children with asthma using WheezeScan™ technology may improve asthma control assessments and management. This AI-based device aids in reliable wheeze detection, enhancing care for pediatric asthma patients.
Area of Science:
- Pediatric Pulmonology
- Digital Health Technologies
- Artificial Intelligence in Medicine
Background:
- Asthma control and quality-of-life assessments in children often rely on wheeze detection.
- Parental and physician detection of wheeze shows significant disagreement (>50%), impacting accurate asthma management.
- Objective wheeze identification using WheezeScan™, an AI-based device, could enhance asthma control assessment.
Purpose of the Study:
- To determine if WheezeScan™ improves parental asthma control assessment (ACA) in children (aged 4-11).
- To evaluate WheezeScan™'s impact on patient-reported outcomes (PROs), parent asthma management self-efficacy (PAMS), healthcare costs, and ease of use.
- To test the hypothesis that WheezeScan™ use alters ACA in pediatric asthma patients.
Main Methods:
- A multicenter prospective cohort study involving 125 children with confirmed asthma.
- Parents/caregivers used WheezeScan™ twice daily for 5 weeks, with potential medication adjustments based on scores.
- Primary endpoint: proportion of children with changed asthma control assessment between baseline and week 1, using WheezeScan™ data.
Main Results:
- The study protocol outlines the methodology for assessing WheezeScan™'s effectiveness.
- Data collection includes baseline, week 1, and week 5 assessments.
- Secondary outcomes encompass PROs, PAMS, healthcare costs, and device usability.
Conclusions:
- This study protocol investigates the use of digital technology for accurate wheeze identification in pediatric asthma.
- The aim is to improve asthma assessment and related patient-reported outcomes.
- Potential benefits include enhanced PAMS and reduced healthcare costs through objective wheeze detection.
Background:
Achieving good asthma control is a goal of asthma management. In children, asthma control and quality-of-life assessments include determining the presence of wheeze. However, wheeze is unreliably reported with high disagreement (>50%) between parental and physician detection of wheeze. Objectively defining wheeze using WheezeScan™ (a user-friendly, artificial intelligence-based device) could improve assessment of asthma control and hence management.
Objective:
Our primary aim is to determine whether adding WheezeScan™ to routine clinical care improves parental asthma control assessment (ACA) in children (aged 4-11 years). Our secondary aims are to examine the impact of WheezeScan™ upon patient-reported outcomes (PROs), the parent asthma management self-efficacy scale (PAMS), healthcare costs and ease of WheezeScan™ use. The primary hypothesis is that using WheezeScan™ alters the ACA group.
Methods:
Our multicentre prospective cohort study involves 125 children with specialist-confirmed asthma. Over 5 weeks, parents/caregivers use the WheezeScan™ twice-daily at home and whenever wheezing is suspected. After the first week of using the WheezeScan™, asthma medications may be adjusted based upon the child's asthma control score and WheezeScan™ data. Study outcomes are collected at baseline, week 1 and week 5. Our primary end-point is the proportion of children whose assessment of asthma control changed between week 1 and baseline, based upon parental assessments using WheezeScan™ data. Secondary outcomes are PROs (asthma-related quality of life), PAMS, healthcare costs and WheezeScan™ ease of use.
Conclusions:
This protocol describes our study to determine whether using digital technology to accurately identify wheeze in children with asthma improves their asthma assessment and asthma-related PROs, including PAMS and healthcare costs.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Inhaled Medications
Asthma-III: Symptoms and Complications
Classification of Asthma
